Q’Apel Medical Announces CE Mark Approval for Armadillo SelectFlex™ Neur...
Fremont, CA – January 13, 2025 – Q’Apel Medical (Q’Apel), a privately held medical device company focused on revolutionizing neurovascular interventions, today announced it has received CE mark certification for its Armadillo SelectFlex™ Neurovascular Access System. The first-of-its-kind 7F system features the patented SelectFlex™ Technology and is indicated for the introduction of interventional devices into the neurovasculature.